Related Experiment Video
Updated: Jul 20, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Fungal infections and their treatment in the intensive care unit
1Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. george.sarosi@med.va.gov
Purpose Of Review:
To describe and bring together recent development in the diagnosis and treatment of both community-acquired and opportunistic fungal infections in the intensive care unit.
Recent Findings:
The past few years have brought major advances to both the diagnosis and treatment of fungal infections. The development of newer therapeutic modalities to supplement existing treatment options includes a new class of antifungal agents, the echinocandins. Newer and improved agents of the azole class have arrived as well as better delineation for the role of liposomal amphotericins. Newer, nonculture-based diagnostic tests have allowed earlier, more timely diagnosis of opportunistic fungal infections, allowing more rapid initiation of therapy.
Summary:
Improved diagnostic tests and newer antifungal agents have been introduced, leading to earlier diagnosis and treatment.
Related Concept Videos
Cryptococcal Meningitis
Antifungal Agents
Fungal Phylum Microsporidia
Candidiasis
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Endocarditis IV: Nursing Management
